Results 1 to 10 of about 233,909 (167)
“Security dilemma”: active immunotherapy before versus after radiation therapy alone or chemo-radiotherapy for newly diagnosed glioblastoma [PDF]
Folia Medica, 2022 Management of glioblastoma should be aggressive and personalised to increase the quality of life. Many new therapies, such as active immunotherapy, increase the overall survival, yet they result in complications which render the search for the optimal ...
Alexandrina S. Nikova +3 more
doaj +3 more sources
Frontiers in Genetics, 2020 ObjectiveDespite several clinicopathological factors being integrated as prognostic biomarkers, the individual variants and risk stratification have not been fully elucidated in lower grade glioma (LGG).
Mingwei Zhang +10 more
doaj +1 more source
Prognostic Value of a Stemness Index-Associated Signature in Primary Lower-Grade Glioma
Frontiers in Genetics, 2020 ObjectiveAs a prevalent and infiltrative cancer type of the central nervous system, the prognosis of lower-grade glioma (LGG) in adults is highly heterogeneous.
Mingwei Zhang +10 more
doaj +1 more source
Active Immunotherapy for Glioblastoma Treatment: A Systematic Review and Meta-Analysis
Cancer Control, 2022 Introduction Glioblastoma multiforme (GBM) makes 60–70% of gliomas and 15% of primary brain tumors. Despite the availability of standard multimodal therapy, 2 years, 3 years, and 5 years survival rate of GBM are still low.
Joni Wahyuhadi +7 more
doaj +1 more source
The Potency of Herbal Active Compounds as Immune Modulators for Cancer Therapy
Indonesian Journal of Cancer, 2023 Cancer was the second leading cause of death globally in 2018. On the other hand, immunotherapy is one of the most promising and effective therapies to fight against cancer. This area of research has highly increased over the last decade.
Maria Maghdalena +1 more
doaj +1 more source
Active immunotherapy of cancer: An overview of therapeutic vaccines [PDF]
Arhiv za farmaciju, 2019 Cancer is one of the leading causes of morbidity and mortality worldwide and great efforts are underway to develop new therapeutic protocols. One of the approaches is immunotherapy which uses the immune system and its components to fight against cancer ...
Filipić Brankica +1 more
doaj +1 more source
Cancer immunotherapies: advances and bottlenecks
Frontiers in Immunology, 2023 Immunotherapy has ushered in a new era in cancer treatment, and cancer immunotherapy continues to be rejuvenated. The clinical goal of cancer immunotherapy is to prime host immune system to provide passive or active immunity against malignant tumors ...
Rui Rui +11 more
doaj +1 more source
Magnetically Actuated Biodegradable Nanorobots for Active Immunotherapy
Advanced Science, 2023 An efficient and cost‐effective therapeutic vaccine is highly desirable for the prevention and treatment of cancer, which helps to strengthen the immune system and activate the T cell immune response.
Yicheng Ye +11 more
doaj +1 more source
Beyond the immune suppression: the immunotherapy in prostate cancer [PDF]
, 2015 Prostate cancer (PCa) is the second most common cancer in men.Aswell in many other human cancers, inflammation and immune suppression have an important role in their development.We briefly describe the host components that interact with the tumor to ...
Agliano', Anna Maria +4 more
core +7 more sources
Immunotherapy, Inflammation and Colorectal Cancer. [PDF]
, 2020 Colorectal cancer (CRC) is the third most common cancer type, and third highest in mortality rates among cancer-related deaths in the United States.
Karin, Michael +3 more
core +1 more source